RAREsummit19

speaker profile
 
 

Dr. Andy Richards, CBE

Digital Health Entrepreneur, healthcare and life sciences chairman and director

Cambridge Rare Disease Network - RAREsummit19 | Andy Richards 1

Moderated Discussion: Disruptive technologies – Patients at the heart of AI

Bio: Andy is an entrepreneur and investor with an established track record in founding and scaling up innovative Life-science, Biotechnology and Healthtech companies in the UK. He is currently Chairman of Arecor, Congenica, Abcodia, Closed Loop Medicine and the Babraham Research Campus and is a Director of Ieso Digital Health, Owlstone Medical, and Cancer Research Technology (commercial arm of CR-UK). He is an advisor to several investment funds including Cambridge Innovation Capital and the UCL Technology Fund and a director of the Scale-Up Institute.

Andy is a Cambridge Graduate with a PhD in Chemistry and an early career spanning positions with ICI (now AstraZeneca) and PA Technology. He was a founder and executive director of Chiroscience plc until its merger with Celltech in 1999 and since that time he has founded, invested in and helped to scale more than 25 innovative ventures including companies such as Vectura, Arakis, Cambridge Biotechnology Ltd and Geneservice.  Andy is also a founder member of the Cambridge Angels. He received a CBE for services to life-science investment in 2015.

WP Feedback

Dive straight into the feedback!
Login below and you can start commenting using your own user instantly

CRDN sign up to newsletter

Sign up to our monthly newsletter packed with news & events. Join our thriving rare disease community.

 

You have Successfully Subscribed!

Cookie Box Settings